Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Tenaya Therapeutics has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Tenaya Therapeutics's investors include RA Capital Management, RTW Investments, The Column Group, Fidelity, Google Ventures.
Tenaya Therapeutics is headquartered in San Francisco, United States.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Tenaya Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tenaya Therapeutics — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/tenaya-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Tenaya Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/tenaya-therapeutics
{{cite web |title=Tenaya Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tenaya-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated